Study of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated Radiation ThErapy and TEmozolomide in Newly Diagnosed GLioblastoma (GBM) Patients
Clinical trial NCT06477939 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06477939
- Sponsor
- Institut de cancérologie Strasbourg Europe
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-01
- Primary completion
- 2032-12-31
- Enrollment
- 554
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.